FDA issued a Warning Letter to Cadila Healthcare Limited on 6/21/2011 for a previous inspection.
483 Cadila Healthcare Sep 2014

483 Cadila Healthcare Sep 2014

Eric Mueller FDA, Katherine Szestypalow FDA$119.00 - Available Now

FDA investigators audited the Cadila Healthcare - Ahmedabad, India facility and issued 4 inspectional observations (via FDA 483) on 05 Sep 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 05 Sep 2014
  • Location: Ahmedabad, India
  • FEI: 3002984011
Add To Cart